Skip to search formSkip to main contentSkip to account menu

ibafloxacin

Known as: 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-, 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Quinolizines

Narrower (1)

S 25930

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods
Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated… 
2011
2011
Bioavailability and Pharmacokinetics of Ibafloxacin in Ewes
2007
2007
Pharmacokinetics and milk penetration of ibafloxacin after intravenous administration to lactating goats.
The pharmacokinetic behavior of ibafloxacin was studied after intravenous administration of a single dose of 15 mg/kg to 6… 
2007
2007
Valutazione dell’efficacia dell’associazione ibafloxacin-metronidazolo nella terapia della leishmaniosi canina: studio preliminare
RIASSUNTO Nello studio e stata valutata l’efficacia dell’associazione ibafloxacin-metronidazolo nei confronti di Leishmania… 
2006
2006
Clinical efficacy of two ibafloxacin formulations in the treatment of canine pyoderma
PYODERMA is an inflammatory skin disease that is encountered commonly in veterinary practice in dogs. Although pyoderma is… 
2005
2005
Pharmacokinetics of ibafloxacin in healthy cats.
The pharmacokinetics of ibafloxacin following single and repeated administration of an oral gel formulation and the effect of… 
2005
2005
Pharmacodynamics of ibafloxacin in micro-organisms isolated from cats.
The pharmacodynamic properties of ibafloxacin were investigated in micro-organisms isolated from cats. Minimal inhibitory… 
2004
2004
Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles.
Dogs with superficial or deep pyoderma (n = 228) presented to first opinion veterinarians (n = 20) were treated orally with… 
2002
2002
Pharmacokinetics of ibafloxacin following intravenous and oral administration to healthy Beagle dogs.
The pharmacokinetics of ibafloxacin, a new veterinary fluoroquinolone antimicrobial agent, was studied following intravenous (i.v… 
1997
1997
Ibafloxacin for treatment of wound infection and cystitis in experimental models in dogs
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)